This HTML5 document contains 37 embedded RDF statements represented using HTML+Microdata notation.

The embedded RDF content will be recognized by any processor of HTML5 Microdata.

Namespace Prefixes

PrefixIRI
n13http://linked.opendata.cz/resource/drugbank/drug/DB03903/identifier/pubchem-compound/
n2http://linked.opendata.cz/resource/drugbank/drug/
dctermshttp://purl.org/dc/terms/
n10http://linked.opendata.cz/resource/drugbank/drug/DB03903/identifier/pubchem-substance/
n7http://linked.opendata.cz/resource/drugbank/drug/DB03903/identifier/drugbank/
n9http://bio2rdf.org/drugbank:
admshttp://www.w3.org/ns/adms#
n6http://linked.opendata.cz/resource/drugbank/drug/DB03903/identifier/chemspider/
n11http://wifo5-03.informatik.uni-mannheim.de/drugbank/resource/drugs/
rdfhttp://www.w3.org/1999/02/22-rdf-syntax-ns#
owlhttp://www.w3.org/2002/07/owl#
n3http://linked.opendata.cz/ontology/drugbank/
n4http://linked.opendata.cz/resource/drugbank/property/
xsdhhttp://www.w3.org/2001/XMLSchema#
n12http://linked.opendata.cz/resource/drugbank/drug/DB03903/identifier/pdb/

Statements

Subject Item
n2:DB03903
rdf:type
n3:Drug
n3:group
experimental
owl:sameAs
n9:DB03903 n11:DB03903
dcterms:title
Tmr
adms:identifier
n6:4451283 n7:DB03903 n10:46506730 n12:RHO n13:5289288
n3:synthesisReference
Cherng-Chyi Han, Rodney Lee, "Method to make small isolated features with pseudo-planarization for TMR and MRAM applications." U.S. Patent US20050112902, issued May 26, 2005.
n3:IUPAC-Name
n4:271B4DE8-363D-11E5-9242-09173F13E4C5
n3:InChI
n4:271B4DEE-363D-11E5-9242-09173F13E4C5
n3:Molecular-Formula
n4:271B4DED-363D-11E5-9242-09173F13E4C5
n3:Molecular-Weight
n4:271B4DEA-363D-11E5-9242-09173F13E4C5
n3:Monoisotopic-Weight
n4:271B4DEB-363D-11E5-9242-09173F13E4C5
n3:SMILES
n4:271B4DEC-363D-11E5-9242-09173F13E4C5
n3:Water-Solubility
n4:271B4DE6-363D-11E5-9242-09173F13E4C5
n3:logP
n4:271B4DE4-363D-11E5-9242-09173F13E4C5 n4:271B4DE7-363D-11E5-9242-09173F13E4C5
n3:logS
n4:271B4DE5-363D-11E5-9242-09173F13E4C5
n3:H-Bond-Acceptor-Count
n4:271B4DF4-363D-11E5-9242-09173F13E4C5
n3:H-Bond-Donor-Count
n4:271B4DF5-363D-11E5-9242-09173F13E4C5
n3:InChIKey
n4:271B4DEF-363D-11E5-9242-09173F13E4C5
n3:Polar-Surface-Area--PSA-
n4:271B4DF0-363D-11E5-9242-09173F13E4C5
n3:Polarizability
n4:271B4DF2-363D-11E5-9242-09173F13E4C5
n3:Refractivity
n4:271B4DF1-363D-11E5-9242-09173F13E4C5
n3:Rotatable-Bond-Count
n4:271B4DF3-363D-11E5-9242-09173F13E4C5
n3:Bioavailability
n4:271B4DFA-363D-11E5-9242-09173F13E4C5
n3:Ghose-Filter
n4:271B4DFC-363D-11E5-9242-09173F13E4C5
n3:MDDR-Like-Rule
n4:271B4DFD-363D-11E5-9242-09173F13E4C5
n3:Number-of-Rings
n4:271B4DF9-363D-11E5-9242-09173F13E4C5
n3:Physiological-Charge
n4:271B4DF8-363D-11E5-9242-09173F13E4C5
n3:Rule-of-Five
n4:271B4DFB-363D-11E5-9242-09173F13E4C5
n3:Traditional-IUPAC-Name
n4:271B4DE9-363D-11E5-9242-09173F13E4C5
n3:pKa--strongest-acidic-
n4:271B4DF6-363D-11E5-9242-09173F13E4C5
n3:pKa--strongest-basic-
n4:271B4DF7-363D-11E5-9242-09173F13E4C5